e-learning | Sotagliflozin with insulin for type 1 diabetes

2nd June 2020 by Louise Hudman

e-learning | Sotagliflozin with insulin for type 1 diabetes

This is a new guideline from NICE published in Feb 2020 advising that sotagliflozin can be used alongside insulin for type 1 diabetes.

Sotagliflozin is an SGLT1 and SGLT2 inhibitor. It is only licensed for type 1 diabetes, not for type 2 diabetes.

Dapagliflozin was endorsed by NICE in Aug 19 as a treatment for type 1 diabetes. Sotagliflozin has exactly the same restrictions on its use. It improves HbA1c, brings greater weight loss and improves quality of life. It is presumed that this drop in HbA1c will lead to a lower risk of complications from diabetes, though this hasn’t yet been shown.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"LocumDeck does everything you want it to do in an instant and with audit trails.

I absolutely love the facility for receiving Locum's invoices and the facility for signing the Pension Forms electronically and they are then instantly sent with an audit trail! It is fabulous!

You are notified the moment a Locum GP adds availability which is just fantastic, I spend a lot of time just chasing agencies to see if they have availability, so to be notified the moment availability is advertised is a new concept and very welcome! I have no hesitation in recommending LocumDeck - it has already eased my workload!"

Sue, Practice Manager in Portsmouth

See the full list of features within our NASGP membership plans

Membership